Tracked deals
4
4 tracked deals across 2019-2026.
Brisbane, California, United States
Precision medicine company focused on clinically differentiated diagnostic solutions and digital/transplant surveillance management for transplant patients and caregivers.
Tracked deals
4
4 tracked deals across 2019-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
4 buyout
Last 3 years
Supporting Data
CareDx entered into a definitive agreement to acquire Naveris, a commercial-stage precision oncology diagnostics company, for $160 million upfront cash plus up to $100 million in revenue-based milestones. The acquisition extends CareDx’s precision medicine testing strategy into specialty oncology via Naveris’ NavDx liquid biopsy platform for viral-mediated cancers and MRD surveillance, with an anticipated close in Q3 2026 subject to customary conditions.
CareDx, Inc. acquired MediGO, Inc., a provider of organ transplant supply-chain logistics software, to expand its digital health offerings for organ procurement organizations (OPOs) and strengthen pre-transplant capabilities. The acquisition is intended to accelerate operational efficiencies, increase organ utilization, and broaden CareDx's transplant ecosystem solutions.
CareDx, Inc. completed the acquisition of XynManagement, a provider of transplant quality-tracking software (XynQAPI) and waitlist management services. The deal adds pre-transplant patient outreach and analytics capabilities to CareDx's Digital Solutions portfolio and will integrate XynManagement products with CareDx offerings to expand patient reach and transplant analytics.
CareDx, Inc. agreed to acquire OTTR Complete Transplant Management, a provider of organ transplant patient-tracking software used by transplant centers in the US and Canada. The strategic acquisition (approximately $16.0 million) will integrate OTTR's EMR-integrated transplant management tools with CareDx's transplant diagnostics to streamline ordering and patient surveillance.
Turn tracked acquisition activity into an outreach-ready buyer list.